Pfizer pulled its preliminary application for an EUA for covid shots for babies (6 months to 4 years) due to ‘lack of data’.
This comes on the heels of a redline updates to its business rick disclosures in its Q4 reports that indicate something about:
“…risks associated with…further information regarding the quality of pre-clinical, clinical or safety data, including by audit or inspection;”
…
“…challenges related to public confidence or awareness of our COVID-19 vaccine or Paxlovid, including challenges driven by misinformation, access, concerns about clinical data integrity and prescriber and pharmacy education;”…“…the possibility that COVID-19 will diminish in severity or prevalence, or disappear entirely;”
Of course the report was promptly squished and the BMJ, one of the oldest medical publications EVER was sidelined. They aren’t taking it lying down.
ETA: The CDC is thinking about recommending a longer spacing between shots (shouldn’t that be the FDA’s job?) because of that totally ‘rare’ myocarditis and other heart problems. Most articles you read try to minimize that aspect, but at least they are saying it.
Midwest Chick's Place 
Leave a Reply